These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 10472570

  • 1. Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors.
    Fulda S, Jeremias I, Pietsch T, Debatin KM.
    Klin Padiatr; 1999; 211(4):319-22. PubMed ID: 10472570
    [Abstract] [Full Text] [Related]

  • 2. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors.
    Fulda S, Debatin KM.
    Med Pediatr Oncol; 2000 Dec; 35(6):616-8. PubMed ID: 11107130
    [Abstract] [Full Text] [Related]

  • 3. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors.
    Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nuñez G, Krammer PH, Peter ME, Debatin KM.
    Cancer Res; 1997 Nov 01; 57(21):4956-64. PubMed ID: 9354463
    [Abstract] [Full Text] [Related]

  • 4. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
    Fulda S, Jeremias I, Steiner HH, Pietsch T, Debatin KM.
    Int J Cancer; 1999 Jul 30; 82(3):435-41. PubMed ID: 10399962
    [Abstract] [Full Text] [Related]

  • 5. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid.
    Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME, Debatin KM.
    J Biol Chem; 1998 Dec 18; 273(51):33942-8. PubMed ID: 9852046
    [Abstract] [Full Text] [Related]

  • 6. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.
    Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, Geilen CC.
    J Invest Dermatol; 2001 Aug 18; 117(2):333-40. PubMed ID: 11511312
    [Abstract] [Full Text] [Related]

  • 7. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.
    Fulda S, Susin SA, Kroemer G, Debatin KM.
    Cancer Res; 1998 Oct 01; 58(19):4453-60. PubMed ID: 9766678
    [Abstract] [Full Text] [Related]

  • 8. Correspondence re: S. Fulda et al., Betulinic acid triggers CD95 (Apo1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res., 57: 4956-4964, 1997.
    Rieber M, Rieber MS.
    Cancer Res; 1998 Dec 15; 58(24):5876-7. PubMed ID: 9865749
    [No Abstract] [Full Text] [Related]

  • 9. Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashion.
    Mullauer FB, Kessler JH, Medema JP.
    Apoptosis; 2009 Feb 15; 14(2):191-202. PubMed ID: 19115109
    [Abstract] [Full Text] [Related]

  • 10. Betulinic acid, a natural compound with potent anticancer effects.
    Mullauer FB, Kessler JH, Medema JP.
    Anticancer Drugs; 2010 Mar 15; 21(3):215-27. PubMed ID: 20075711
    [Abstract] [Full Text] [Related]

  • 11. Betulinic acid induces Bax/Bak-independent cytochrome c release in human nasopharyngeal carcinoma cells.
    Liu Y, Luo W.
    Mol Cells; 2012 May 15; 33(5):517-24. PubMed ID: 22526391
    [Abstract] [Full Text] [Related]

  • 12. Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses.
    Twardziok M, Meierhofer D, Börno S, Timmermann B, Jäger S, Boral S, Eggert A, Delebinski CI, Seifert G.
    BMC Complement Altern Med; 2017 Apr 28; 17(1):237. PubMed ID: 28454538
    [Abstract] [Full Text] [Related]

  • 13. Targeting mitochondrial apoptosis by betulinic acid in human cancers.
    Fulda S, Kroemer G.
    Drug Discov Today; 2009 Sep 28; 14(17-18):885-90. PubMed ID: 19520182
    [Abstract] [Full Text] [Related]

  • 14. Betulinic acid induces apoptosis in human neuroblastoma cell lines.
    Schmidt ML, Kuzmanoff KL, Ling-Indeck L, Pezzuto JM.
    Eur J Cancer; 1997 Oct 28; 33(12):2007-10. PubMed ID: 9516843
    [Abstract] [Full Text] [Related]

  • 15. Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells.
    Fulda S, Jeremias I, Debatin KM.
    Oncogene; 2004 Oct 07; 23(46):7611-20. PubMed ID: 15361826
    [Abstract] [Full Text] [Related]

  • 16. Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells.
    Pandey MK, Sung B, Aggarwal BB.
    Int J Cancer; 2010 Jul 15; 127(2):282-92. PubMed ID: 19937797
    [Abstract] [Full Text] [Related]

  • 17. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing.
    Wick W, Grimmel C, Wagenknecht B, Dichgans J, Weller M.
    J Pharmacol Exp Ther; 1999 Jun 15; 289(3):1306-12. PubMed ID: 10336521
    [Abstract] [Full Text] [Related]

  • 18. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation.
    Tan Y, Yu R, Pezzuto JM.
    Clin Cancer Res; 2003 Jul 15; 9(7):2866-75. PubMed ID: 12855667
    [Abstract] [Full Text] [Related]

  • 19. Betulinic acid: a natural product with anticancer activity.
    Fulda S.
    Mol Nutr Food Res; 2009 Jan 15; 53(1):140-6. PubMed ID: 19065582
    [Abstract] [Full Text] [Related]

  • 20. Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells.
    Thurnher D, Turhani D, Pelzmann M, Wannemacher B, Knerer B, Formanek M, Wacheck V, Selzer E.
    Head Neck; 2003 Sep 15; 25(9):732-40. PubMed ID: 12953308
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.